• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤型红斑狼疮患者对口服和外用药物的依从性尚未得到充分描述。

Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.

作者信息

Farhangian Michael E, Huang William W, Feldman Steven R

机构信息

Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA,

出版信息

Dermatol Ther (Heidelb). 2015 Jun;5(2):91-105. doi: 10.1007/s13555-015-0075-4. Epub 2015 Apr 22.

DOI:10.1007/s13555-015-0075-4
PMID:25899142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4470959/
Abstract

INTRODUCTION

Treatment adherence plays a large role in chronic dermatologic diseases and may play an important role in the outcomes of patients with cutaneous lupus erythematosus (CLE). We sought to gauge what is currently known about adherence to topical and oral medications in patients with CLE.

METHODS

A review of MEDLINE was performed using a combination of the phrases "adherence", "compliance", "lupus", and "cutaneous". Studies were hand searched and prospective and cross-sectional studies evaluating medication adherence in patients with CLE and systemic lupus erythematosus (SLE) were included.

RESULTS

Only two articles explored adherence in patients with CLE, while 17 articles discussed treatment adherence in patients with SLE. Depression was consistently cited as detrimental to adherence. The impact that race, ethnicity, and education has on adherence is unclear. Three studies noted a clear connection between adherence and disease activity, while two others did not. Few studies investigated methods that have improved adherence to treatment which have showed promise.

CONCLUSION

Much of what we know about adherence to medication in patients with lupus is limited to SLE. Although cutaneous symptoms are among the most common manifestations of SLE, cutaneous disease is often managed at least in part with topical agents, and adherence to topical treatment was not assessed in any of the articles, though one study investigated sunscreen usage in patients with CLE. Understanding adherence in patients with CLE may help contribute to better CLE treatment outcomes.

摘要

引言

治疗依从性在慢性皮肤病中起着重要作用,可能对皮肤红斑狼疮(CLE)患者的治疗结果也很重要。我们试图了解目前关于CLE患者局部和口服药物依从性的情况。

方法

使用“依从性”“顺应性”“狼疮”和“皮肤”等短语组合对MEDLINE进行检索。对手检的研究进行筛选,纳入评估CLE和系统性红斑狼疮(SLE)患者药物依从性的前瞻性和横断面研究。

结果

仅有两篇文章探讨了CLE患者的依从性,而有17篇文章讨论了SLE患者的治疗依从性。抑郁一直被认为对依从性有不利影响。种族、民族和教育对依从性的影响尚不清楚。三项研究指出依从性与疾病活动之间存在明确联系,而另外两项研究则未发现此联系。很少有研究调查能改善治疗依从性且显示出前景的方法。

结论

我们对狼疮患者药物依从性的了解大多局限于SLE。虽然皮肤症状是SLE最常见的表现之一,但皮肤病通常至少部分通过局部用药治疗,且在任何文章中均未评估局部治疗的依从性,不过有一项研究调查了CLE患者使用防晒霜的情况。了解CLE患者的依从性可能有助于改善CLE的治疗结果。

相似文献

1
Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.皮肤型红斑狼疮患者对口服和外用药物的依从性尚未得到充分描述。
Dermatol Ther (Heidelb). 2015 Jun;5(2):91-105. doi: 10.1007/s13555-015-0075-4. Epub 2015 Apr 22.
2
Management of cutaneous manifestations of lupus erythematosus: A systematic review.红斑狼疮皮肤表现的治疗:系统评价。
Semin Arthritis Rheum. 2020 Feb;50(1):95-127. doi: 10.1016/j.semarthrit.2019.07.010. Epub 2019 Aug 12.
3
Immunogenetics of cutaneous lupus erythematosus.皮肤红斑狼疮的免疫遗传学
Curr Opin Pediatr. 2016 Aug;28(4):470-5. doi: 10.1097/MOP.0000000000000383.
4
Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.无系统性红斑狼疮的皮肤型红斑狼疮:临床及实验室特征
Semin Arthritis Rheum. 1992 Feb;21(4):221-6. doi: 10.1016/0049-0172(92)90052-f.
5
Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.伴有和不伴有系统性红斑狼疮的皮肤红斑狼疮的发病机制。
Autoimmun Rev. 2017 Jul;16(7):735-742. doi: 10.1016/j.autrev.2017.05.009. Epub 2017 May 5.
6
Monoclonal antibodies for the management of cutaneous lupus erythematosus: an update on the current treatment landscape.用于治疗皮肤红斑狼疮的单克隆抗体:当前治疗格局的最新进展
Clin Exp Dermatol. 2025 Jan 27;50(2):314-322. doi: 10.1093/ced/llae374.
7
Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.皮肤红斑狼疮与系统性红斑狼疮的关联:瑞典一项基于人群的 1088 例患者队列研究。
Br J Dermatol. 2011 Jun;164(6):1335-41. doi: 10.1111/j.1365-2133.2011.10272.x. Epub 2011 May 17.
8
A review of the evidence and cost of therapies for cutaneous lupus erythematosus.皮肤红斑狼疮治疗的证据和成本综述。
Lupus. 2019 Jun;28(7):799-805. doi: 10.1177/0961203319846397. Epub 2019 May 1.
9
Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.患有红斑狼疮和系统性红斑狼疮的患者患抑郁症的风险增加:一项丹麦全国性队列研究。
Br J Dermatol. 2018 Nov;179(5):1095-1101. doi: 10.1111/bjd.16831. Epub 2018 Sep 5.
10
Novel biological therapeutic approaches to cutaneous lupus erythematosus.治疗红斑狼疮的新型生物疗法。
Expert Opin Biol Ther. 2018 Oct;18(10):1041-1047. doi: 10.1080/14712598.2018.1513484. Epub 2018 Sep 5.

引用本文的文献

1
Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort.系统性红斑狼疮持续疾病活动和长期缓解的预测因素:霍普金斯狼疮队列研究结果
Lupus Sci Med. 2018 Nov 2;5(1):e000287. doi: 10.1136/lupus-2018-000287. eCollection 2018.
2
Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.医疗保险受益人群中系统性红斑狼疮患者羟氯喹不依从的动态模式和预测因素。
Semin Arthritis Rheum. 2018 Oct;48(2):205-213. doi: 10.1016/j.semarthrit.2018.01.002. Epub 2018 Jan 8.
3
Treatment of Psychiatric Disorders and Skin-Restricted Lupus Remission: A Longitudinal Study.治疗精神障碍和皮肤局限型狼疮缓解:一项纵向研究。
JAMA Dermatol. 2017 Dec 1;153(12):1331-1332. doi: 10.1001/jamadermatol.2017.3590.
4
Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.治疗皮肤红斑狼疮的选择:最新进展和未来前景。
Expert Rev Clin Immunol. 2016 Oct;12(10):1109-21. doi: 10.1080/1744666X.2016.1188006. Epub 2016 Jun 1.

本文引用的文献

1
Sunscreen use in patients with cutaneous lupus erythematosus.皮肤红斑狼疮患者使用防晒霜的情况。
Br J Dermatol. 2015 Sep;173(3):831-4. doi: 10.1111/bjd.13736. Epub 2015 Jul 22.
2
Determinants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia Governorate.埃及东部省系统性红斑狼疮患者药物治疗不依从性的决定因素
Rheumatol Int. 2015 Jun;35(6):1045-51. doi: 10.1007/s00296-014-3182-0. Epub 2014 Nov 26.
3
Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort.在一个城市多民族狼疮队列中,教育程度的提高与依从性降低相关。
J Clin Cell Immunol. 2014 Jun;5(3). doi: 10.4172/2155-9899.1000215.
4
Non-adherence and measures to improve adherence in the topical treatment of psoriasis.银屑病局部治疗中的不依从性及提高依从性的措施。
J Eur Acad Dermatol Venereol. 2014 May;28 Suppl 2:4-9. doi: 10.1111/jdv.12445.
5
Adherence to best practice guidelines in chronic spontaneous urticaria (CSU) improves patient outcome.在慢性自发性荨麻疹(CSU)中遵循最佳实践指南可改善患者预后。
Eur J Dermatol. 2014 May-Jun;24(3):385-6. doi: 10.1684/ejd.2014.2323.
6
Medical adherence to acne therapy: a systematic review.痤疮治疗的药物依从性:一项系统评价。
Am J Clin Dermatol. 2014 Apr;15(2):87-94. doi: 10.1007/s40257-014-0063-y.
7
Adherence to treatment in systemic lupus erythematosus patients.系统性红斑狼疮患者的治疗依从性。
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):329-40. doi: 10.1016/j.berh.2013.07.001.
8
The impact of skin damage due to cutaneous lupus on quality of life.皮肤狼疮导致的皮肤损伤对生活质量的影响。
Br J Dermatol. 2014 Feb;170(2):315-21. doi: 10.1111/bjd.12653.
9
Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study.中度或重度特应性皮炎维持治疗患者的健康相关生活质量、患者满意度及治疗依从性:CONDA-SAT研究
Actas Dermosifiliogr. 2013 Jun;104(5):409-17. doi: 10.1016/j.adengl.2013.04.004. Epub 2013 May 10.
10
Adherence to medication in patients with psoriasis: a systematic literature review.银屑病患者的药物依从性:系统文献回顾。
Br J Dermatol. 2013 Jan;168(1):20-31. doi: 10.1111/bjd.12039.